Detalhe da pesquisa
1.
Safety and efficacy of topical artesunate for the treatment of vulvar intraepithelial neoplasia 2/3.
Gynecol Oncol
; 178: 102-109, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37839312
2.
Correction: Defining the genetic susceptibility to cervical neoplasia-A genome-wide association study.
PLoS Genet
; 14(3): e1007257, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29494589
3.
Current status of therapeutic HPV vaccines.
Gynecol Oncol
; 156(2): 503-510, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31870557
4.
A first-in-human proof-of-concept trial of intravaginal artesunate to treat cervical intraepithelial neoplasia 2/3 (CIN2/3).
Gynecol Oncol
; 157(1): 188-194, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32005582
5.
Defining the genetic susceptibility to cervical neoplasia-A genome-wide association study.
PLoS Genet
; 13(8): e1006866, 2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28806749
6.
HLA and KIR Associations of Cervical Neoplasia.
J Infect Dis
; 218(12): 2006-2015, 2018 11 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30099516
7.
Human papilloma virus-specific T cells can be generated from naïve T cells for use as an immunotherapeutic strategy for immunocompromised patients.
Cytotherapy
; 20(3): 385-393, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29331266
8.
Safety, efficacy, and immunogenicity of VGX-3100, a therapeutic synthetic DNA vaccine targeting human papillomavirus 16 and 18 E6 and E7 proteins for cervical intraepithelial neoplasia 2/3: a randomised, double-blind, placebo-controlled phase 2b trial.
Lancet
; 386(10008): 2078-2088, 2015 Nov 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-26386540
9.
A pilot study of pNGVL4a-CRT/E7(detox) for the treatment of patients with HPV16+ cervical intraepithelial neoplasia 2/3 (CIN2/3).
Gynecol Oncol
; 140(2): 245-52, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26616223
10.
Towards identifying new therapeutic targets in cancers attributable to HPV.
Gynecol Oncol
; 149(2): 225-226, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29685611
11.
Is bilateral lymphadenectomy for midline squamous carcinoma of the vulva always necessary? An analysis from Gynecologic Oncology Group (GOG) 173.
Gynecol Oncol
; 128(2): 155-9, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23201592
12.
A phase I study of intra-anal artesunate (suppositories) to treat anal high-grade squamous intraepithelial lesions.
PLoS One
; 18(12): e0295647, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38100463
13.
Karyometry in atypical endometrial hyperplasia: a Gynecologic Oncology Group study.
Gynecol Oncol
; 125(1): 129-35, 2012 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-22155796
14.
Human papillomavirus 16-associated cervical intraepithelial neoplasia in humans excludes CD8 T cells from dysplastic epithelium.
J Immunol
; 185(11): 7107-14, 2010 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21037100
15.
Impact of payer status on treatment of cervical cancer at a tertiary referral center.
Gynecol Oncol
; 122(2): 324-7, 2011 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-21620446
16.
Tc17 CD8 T cells: functional plasticity and subset diversity.
J Immunol
; 183(11): 7161-8, 2009 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19917680
17.
TCR-engineered T cells targeting E7 for patients with metastatic HPV-associated epithelial cancers.
Nat Med
; 27(3): 419-425, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33558725
18.
Naturally occurring systemic immune responses to HPV antigens do not predict regression of CIN2/3.
Cancer Immunol Immunother
; 59(5): 799-803, 2010 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-20012604
19.
A phase I trial of a human papillomavirus DNA vaccine for HPV16+ cervical intraepithelial neoplasia 2/3.
Clin Cancer Res
; 15(1): 361-7, 2009 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19118066
20.
Development of therapeutic HPV vaccines.
Lancet Oncol
; 10(10): 975-80, 2009 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-19796749